The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene

被引:34
作者
Chen, Lingxia
Zhu, Fuxiang
Li, Juan
Lu, Hui
Jiang, Haiyan
Sarkar, Rita
Arruda, Valder R.
Wang, Jinhui
Zhao, Jennifer
Pierce, Glenn F.
Ding, Qiulan
Wang, Xuefeng
Wang, Hongli
Pipe, Steven W.
Liu, Xiang-Qin
Xiao, Xiao
Camire, Rodney M.
Xiao, Weidong
机构
[1] Univ Penn, Med Ctr, Dept Pediat, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada
[4] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA
[5] Bayer HealthCare Pharmaceut, Berkeley, CA USA
[6] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China
[7] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
[8] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
关键词
D O I
10.1038/sj.mt.6300268
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Coagulation factor VIII (FVIII) is secreted as a heterodimer consisting of a heavy chain (HC) and a light chain (LC), which can be expressed independently and reassociate with recovery of biological activity. Because of the size limitation of adeno-associated virus (AAV) vectors, a strategy for delivering the HC and LC separately has been developed. However, the FVIII HC is secreted 10-100-fold less efficiently than the LC. In this study, we demonstrated that the F309S mutation and enhanced B-domain glycosylations alone are not sufficient to improve FVIII HC secretion, which suggested a role of the FVIII LC in regulating HC secretion. To characterize this role of the FVIII LC, we compared FVIII HC secretion with and without the LC via post-translational protein trans-splicing. As demonstrated in vitro, ligation of the LC to the HC significantly increased HC secretion. Such HC secretion increases were also confirmed in vivo by hydrodynamic injection of FVIII intein plasmids into hemophilia A mice. Moreover, similar enhancement of HC secretion can also be observed when the LC is supplied in trans, which is probably due to the spontaneous association of the HC and the LC in the secretion pathway. In sum, enhancing the secretion of the FVIII HC polypeptide may require the proper association of the FVIII LC polypeptide in cis or in trans. These results may be helpful in designing new strategies to improve FVIII gene delivery.
引用
收藏
页码:1856 / 1862
页数:7
相关论文
共 35 条
[1]   Preclinical pharmacology of albumin-free B-domain deleted recombinant factor VIII [J].
Brinkhous, K ;
Sandberg, H ;
Widlund, L ;
Read, M ;
Nichols, T ;
Sigman, J ;
Oswaldsson, U ;
Schaub, RG ;
Mikaelsson, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (03) :269-272
[2]   Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein [J].
Burton, M ;
Nakai, H ;
Colosi, P ;
Cunningham, J ;
Mitchell, R ;
Couto, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12725-12730
[3]   Preclinical. gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors [J].
Couto, LB .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (02) :161-171
[4]   LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII [J].
Cunningham, MA ;
Pipe, SW ;
Zhang, B ;
Hauri, HP ;
Ginsburg, D ;
Kaufman, RJ .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (11) :2360-2367
[5]  
DORNER AJ, 1989, J BIOL CHEM, V264, P20602
[6]   Haemophilia B: database of point mutations and short additions and deletions - eighth edition [J].
Giannelli, F ;
Green, PM ;
Sommer, SS ;
Poon, MC ;
Ludwig, M ;
Schwaab, A ;
Reitsma, PH ;
Goossens, M ;
Yoshioka, A ;
Figueiredo, MS ;
Brownlee, GG .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :265-268
[7]   Clinical gene transfer studies for hemophilia B [J].
High, KA .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (02) :257-267
[8]   Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs [J].
Jiang, HY ;
Lillicrap, D ;
Patarroyo-White, S ;
Liu, TY ;
Qian, XB ;
Scallan, CD ;
Powell, S ;
Keller, T ;
McMurray, M ;
Labelle, A ;
Nagy, D ;
Vargas, JA ;
Zhou, SZ ;
Couto, LB ;
Pierce, GF .
BLOOD, 2006, 108 (01) :107-115
[9]   Advances toward gene therapy for hemophilia at the millennium [J].
Kaufman, RJ .
HUMAN GENE THERAPY, 1999, 10 (13) :2091-2107
[10]   GENETIC-ENGINEERING OF FACTOR-VIII [J].
KAUFMAN, RJ .
NATURE, 1989, 342 (6246) :207-208